NVAX position history
The shares of Novavax (NVAX) that Shah Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q4: 715,000 shares, $7.4M, 1.7% of portfolio, New
- 2023 Q1: 4,251,076 shares, $29M, 8.6% of portfolio, Add +494.6%
- 2023 Q2: 15,212,588 shares, $111M, 10.5% of portfolio, Add +257.9%
- 2023 Q3: 6,330,756 shares, $46M, 10.8% of portfolio, Reduce −58.4%
- 2023 Q4: 7,780,756 shares, $37M, 9.6% of portfolio, Add +22.9%
- 2024 Q1: 8,117,827 shares, $39M, 10.9% of portfolio, Add +4.3%
- 2024 Q2: 9,662,090 shares, $122M, 26.5% of portfolio, Add +19.0%
- 2024 Q3: 9,815,541 shares, $124M, 24.2% of portfolio, Add +1.6%
- 2024 Q4: 11,148,846 shares, $90M, 18.1% of portfolio, Add +13.6%
- 2025 Q1: 11,131,846 shares, $71M, 14.6% of portfolio, Reduce −0.2%
- 2025 Q2: 11,511,780 shares, $73M, 14.1% of portfolio, Add +3.4%
- 2025 Q3: 11,811,780 shares, $102M, 18.3% of portfolio, Add +2.6%
- 2025 Q4: 14,558,780 shares, $98M, 18.9% of portfolio, Add +23.3%
- 2026 Q1: 14,845,097 shares, $121M, 23.2% of portfolio, Add +2.0%
- 2026 Q2: 14,165,577 shares, $133M, 25.4% of portfolio, Reduce −4.6%
- 2026 Q3: 12,173,481 shares, $132M, 21.7% of portfolio, Reduce −14.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|